Algorics’ CEO Nithiya Ananthakrishnan is to lead the Risk Based Monitoring stream at the upcoming Summit for Clinical Ops Executives (SCOPE) event, taking place from 13-15th February 2018 in Orlando.
Nithiya will chair the ‘Implementing Risk-Based Monitoring – Part 1: Integrating Quality into Clinical Trials’ stream beginning on Tuesday 13th February, which will include presenters from the Metrics Champion Consortium LLC and industry experts from pharma and biotech including speakers from Celgene, Merck, Allergan, EMD Serono, Gilead Sciences and Pfizer.
This stream will provide industry colleagues with guidance on how to holistically and proactively build quality standards into clinical trials with an emphasis on the latest quality standards and guidelines, including the recent ICH-E6 R2 addendum changes, thereby ensuring higher quality clinical trials and laying the foundation for successful risk-based monitoring.
Meet the Team
Join us in the exhibit hall and meet the Algorics team at Booth 813 to learn more about how Acuity can drive your ICH compliant risk based approach to running clinical trials.
Find out more about this key industry event and register here.
Hyatt Regency Orlando
9801 International Drive
Orlando, Florida, USA, 32819
Phone: +1 407 284 1234